Breaking News Instant updates and real-time market news.

VSTM

Verastem

$6.53

0.95 (17.03%)

16:08
06/17/18
06/17
16:08
06/17/18
16:08

Verastem presents duvelisib data at EHA 2018 annual meeting

Verastem announced one oral and three poster presentations at the 23rd Congress of the European Hematology Association being held June 14-17, 2018 in Stockholm, Sweden. Data were presented on the company's lead product candidate, duvelisib, a first-in-class oral dual inhibitor of phosphoinositide 3-kinase-delta and PI3K-gamma. An oral presentation by Matthew Davids, Dana-Farber Cancer Institute, highlighted the latest data from a Phase Ib/II study evaluating duvelisib in combination with FCR as a frontline treatment in younger patients with chronic lymphocytic leukemia. Three poster presentations highlighted additional duvelisib data, including crossover extension results from the Phase 3 DUO study in patients with relapsed or refractory CLL/small lymphocytic lymphoma, and new biomarker analyses on the tumor microenvironment modulation from the DUOTM study and the Phase 2 DYNAMOTM study in patients with refractory indolent non-Hodgkin lymphoma, and the dual PI3K-delta and PI3K-gamma activity of duvelisib in the CONTEMPOTM study in patients with untreated follicular lymphoma who are treated with duvelisib in combination with CD20 antibody immunotherapy. Phase Ib/II study of duvelisib in combination with FCR [dFCR] achieved ORR of 94% and 76% bone marrow MRD negativity in frontline therapy in younger CLL patients. Duvelisib also demonstrated robust clinical activity in CLL with 73% ORR and a median of 15-month PFS in the DUO crossover study of patients who became relapsed/refractory to ofatumumab in DUO. Additional data support the hypothesis that duvelisib, a first-in-class dual inhibitor of PI3K delta/gamma, targets malignant B-cells directly and modulates the tumor microenvironment.

  • 05

    Oct

VSTM Verastem
$6.53

0.95 (17.03%)

06/15/18
CANT
06/15/18
NO CHANGE
Target $17
CANT
Overweight
Verastem capital raise removes overhang, says Cantor Fitzgerald
Cantor Fitzgerald analyst Mara Goldstein believes Verastem's 7.1M share placement to a single institution removes an overhang on the shares. The raise bumps the company's cash to at least $140M, which will go a long way in removing an overhang on the shares ahead of the FDA action date of October 5, Goldstein tells investors in a research note. She continues to believe that the market for duvelisib is larger than Verastem's valuation suggests. Goldstein keeps an Overweight rating on the shares with a $17 price target.
06/06/18
06/06/18
NO CHANGE

Verastem mentioned positively by Agora
Ray Blanco of Breakthrough Technology Alert from Agora set a $15 price target on Verastem shares, according to contacts.
05/02/18
GHSC
05/02/18
INITIATION
Target $14
GHSC
Buy
Verastem initiated with a Buy at Seaport Global
Seaport Global analyst Corey Davis initiated Verastem with a Buy and $14 price target saying investors are giving little credit for duvelisib success, despite positive Phase 3 data in chronic lymphocytic leukemia, positive Phase 2 in fillicular lymphoma, and currently being under priority/accelerated FDA review.
03/08/18
RILY
03/08/18
INITIATION
Target $15
RILY
Buy
Verastem initiated with a Buy at B. Riley FBR
B. Riley FBR analyst George Zavoico started Verastem with a Buy rating and $15 price target. The analyst expects the company to "high the ground running" following the new drug application for duvelisib.

TODAY'S FREE FLY STORIES

EEM

iShares MSCI Emerging Markets ETF

$40.79

0.95 (2.38%)

14:30
10/16/18
10/16
14:30
10/16/18
14:30
Options
Aggressive call spread opened in iShares Emerging Markets Fund »

Aggressive call spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

I

Intelsat

$36.25

3.81 (11.74%)

14:25
10/16/18
10/16
14:25
10/16/18
14:25
Options
Intelsat call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
10/16/18
10/16
14:25
10/16/18
14:25
Conference/Events
Financial Stability Oversight Council to hold a meeting »

The Council will provide…

WBA

Walgreens Boots Alliance

$75.55

0.83 (1.11%)

, AMZN

Amazon.com

$1,811.22

50.23 (2.85%)

14:23
10/16/18
10/16
14:23
10/16/18
14:23
Periodicals
Walgreens CEO says buyout of AmerisourceBergen possible, Bloomberg reports »

Walgreens Boots Alliance…

WBA

Walgreens Boots Alliance

$75.55

0.83 (1.11%)

AMZN

Amazon.com

$1,811.22

50.23 (2.85%)

CVS

CVS Health

$73.05

0.01 (0.01%)

AET

Aetna

$199.90

0.88 (0.44%)

ABC

AmerisourceBergen

$92.51

2.93 (3.27%)

RAD

Rite Aid

$1.05

-0.005 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 25

    Oct

  • 06

    Nov

RP

RealPage

$58.71

2.33 (4.13%)

14:22
10/16/18
10/16
14:22
10/16/18
14:22
Hot Stocks
RealPage pays $3M to settle FTC charges over tenant screening »

RealPage has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

MARA

Marathon Patent Group

$0.62

-0.0034 (-0.55%)

14:18
10/16/18
10/16
14:18
10/16/18
14:18
Hot Stocks
Breaking Hot Stocks news story on Marathon Patent Group »

Merrick D. Okamoto…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
10/16/18
10/16
14:17
10/16/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
10/16/18
10/16
14:16
10/16/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$220.75

5.47 (2.54%)

14:07
10/16/18
10/16
14:07
10/16/18
14:07
Recommendations
Goldman Sachs analyst commentary  »

JMP Securities sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 26

    Oct

DLTR

Dollar Tree

$86.09

5.11 (6.31%)

, DG

Dollar General

$110.50

4.08 (3.83%)

14:07
10/16/18
10/16
14:07
10/16/18
14:07
Recommendations
Dollar Tree, Dollar General, Amazon.com analyst commentary  »

Reported Icahn stake in…

DLTR

Dollar Tree

$86.09

5.11 (6.31%)

DG

Dollar General

$110.50

4.08 (3.83%)

AMZN

Amazon.com

$1,808.50

47.51 (2.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 25

    Oct

CAG

Conagra Brands

$36.10

0.2725 (0.76%)

, PF

Pinnacle Foods

$66.45

0.22 (0.33%)

14:04
10/16/18
10/16
14:04
10/16/18
14:04
Conference/Events
Pinnacle Foods to host special shareholder meeting »

Special Shareholder…

CAG

Conagra Brands

$36.10

0.2725 (0.76%)

PF

Pinnacle Foods

$66.45

0.22 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CRON

Cronos Group

$11.66

-0.07 (-0.60%)

14:00
10/16/18
10/16
14:00
10/16/18
14:00
Options
Cronos short-term calls active as shares see up and down action »

Cronos short-term calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABC

AmerisourceBergen

$90.56

0.98 (1.09%)

, WBA

Walgreens Boots Alliance

$75.52

0.8 (1.07%)

13:50
10/16/18
10/16
13:50
10/16/18
13:50
Periodicals
Walgreens CEO 'doesn't rule out' deal with AmerisourceBergen, Bloomberg says »

Walgreens (WBA) CEO…

ABC

AmerisourceBergen

$90.56

0.98 (1.09%)

WBA

Walgreens Boots Alliance

$75.52

0.8 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

CJREF

Corus Entertainment

$0.00

(0.00%)

13:49
10/16/18
10/16
13:49
10/16/18
13:49
Upgrade
Corus Entertainment rating change  »

Corus Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVMT

Dell Technologies

$95.51

0.52 (0.55%)

13:46
10/16/18
10/16
13:46
10/16/18
13:46
Periodicals
Dell still thinks offer 'in best interest of DVMT shareholders,' Bloomberg says »

Dell Technologies is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:45
10/16/18
10/16
13:45
10/16/18
13:45
General news
U.S. corporate bond update: several financials are on tap »

U.S. corporate bond…

FDC

First Data

$23.61

0.56 (2.43%)

13:40
10/16/18
10/16
13:40
10/16/18
13:40
Options
8K First Data Jan 25 - 27 call spreads trade for 55c »

8K First Data Jan 25 - 27…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 29

    Oct

  • 03

    Mar

SNE

Sony

$57.24

0.99 (1.76%)

, BTC

Bitcoin

$0.00

(0.00%)

13:35
10/16/18
10/16
13:35
10/16/18
13:35
Hot Stocks
Sony developing rights management system for digital content using blockchain »

Sony Corporation, Sony…

SNE

Sony

$57.24

0.99 (1.76%)

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:35
10/16/18
10/16
13:35
10/16/18
13:35
General news
Treasury Option Action: 10-year positioning »

Treasury Option Action:…

TTWO

Take-Two

$131.41

3.43 (2.68%)

, ATVI

Activision Blizzard

$77.79

2.09 (2.76%)

13:31
10/16/18
10/16
13:31
10/16/18
13:31
Hot Stocks
Game On: Pachter says 'Red Dead Online' could be 25% as popular as 'GTA Online' »

Welcome to "Game…

TTWO

Take-Two

$131.41

3.43 (2.68%)

ATVI

Activision Blizzard

$77.79

2.09 (2.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

WHR

Whirlpool

$108.01

2.6 (2.47%)

13:26
10/16/18
10/16
13:26
10/16/18
13:26
Periodicals
AHAM reports U.S. shipments of major home appliances down 0.4% in September »

The Association of Home…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

SYMC

Symantec

$20.20

0.42 (2.12%)

13:25
10/16/18
10/16
13:25
10/16/18
13:25
Options
Symantec call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 06

    Dec

13:25
10/16/18
10/16
13:25
10/16/18
13:25
Conference/Events
Credit Suisse energy analysts to hold an analyst/industry conference call »

Energy Analysts, along…

SGRY

Surgery Partners

$14.56

0.34 (2.39%)

, UNH

UnitedHealth

$270.48

10.68 (4.11%)

13:21
10/16/18
10/16
13:21
10/16/18
13:21
Hot Stocks
Surgery Partners strength attributed to TheDeal.com discussion of M&A potential »

Shares of Surgery…

SGRY

Surgery Partners

$14.56

0.34 (2.39%)

UNH

UnitedHealth

$270.48

10.68 (4.11%)

HCA

HCA Healthcare

$134.76

1.9 (1.43%)

THC

Tenet

$26.32

0.69 (2.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 30

    Oct

  • 06

    Nov

IBM

IBM

$144.39

3.27 (2.32%)

, AMZN

Amazon.com

$1,799.99

39 (2.21%)

13:19
10/16/18
10/16
13:19
10/16/18
13:19
Earnings
Fly Intel: What to watch for in IBM's earnings report »

IBM (IBM) is scheduled to…

IBM

IBM

$144.39

3.27 (2.32%)

AMZN

Amazon.com

$1,799.99

39 (2.21%)

MSFT

Microsoft

$110.61

3.01 (2.80%)

ORCL

Oracle

$48.18

1.06 (2.25%)

GOOG

Alphabet

$1,117.65

25.65 (2.35%)

GOOGL

Alphabet Class A

$1,130.17

28.59 (2.60%)

GRPN

Groupon

$3.59

0.085 (2.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 21

    Oct

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 13

    Nov

  • 28

    Nov

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.